BRISTOL-MYERS SQUIBB COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.12 USD | +2.17% |
|
-1.00% | -19.85% |
| 05-30 | Bristol-Myers Squibb Says Breyanzi Gets FDA Approval as CAR T Cell Therapy for Mantle Cell Lymphoma | MT |
| 05-30 | Bristol Myers: FDA approval for Breyanzi | CF |
Quotes 5-day view
Delayed Quote Nyse| 28/05/2024 | 29/05/2024 | 30/05/2024 | Today | 31/05/2024 | |
|---|---|---|---|---|---|
| Last | 40.49 $ | 40.25 $ | 40.25 $ | 41.09 $ | 41.12 $ |
| Volume | 14 674 452 | 16 492 496 | 16 114 018 | 28 342 083 | 29 392 776 |
| Change | -1.82% | -0.59% | 0.00% | +2.09% | +2.17% |
| Opening | 41.22 | 40.28 | 40.14 | 40.25 | 40.25 |
| High | 41.33 | 40.70 | 40.60 | 41.16 | 41.16 |
| Low | 40.38 | 39.94 | 39.91 | 40.13 | 40.12 |
Performance
| 1 day | +2.68% | ||
| 1 week | -1.00% | ||
| Current month | -6.41% | ||
| 1 month | -6.41% | ||
| 3 months | -19.19% | ||
| 6 months | -16.72% | ||
| Current year | -19.85% | ||
| 1 year | -35.45% | ||
| 3 years | -37.42% | ||
| 5 years | -10.36% | ||
| 10 years | -17.32% |
Volumes
marketsDaily volume
29 392 776
Estimated daily volume
29 392 776
Avg. Volume 20 sessions
14 154 153
Daily volume ratio
2.08
Avg. Volume 20 sessions USD
582 089 542.13
Record volume 1
185 434 200
Record volume 2
123 619 400
Record volume 3
123 585 283
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
81 590 778 864
Net sales (USD)
45 006 000 000
Number of employees
34 100
Sales / Employee (USD)
1 319 824
Free-Float
69.27 %
Free-Float capitalization (USD)
81 502 973 328
Average Daily Capital Traded
0.71%
Highs and lows
1 week
39.91
41.33
1 month
39.9145.72
Current year
39.9155.04
1 year
39.9166.46
3 years
39.9181.44
5 years
39.9181.44
10 years
39.9181.44
Indicators
Moving average 5 days
40.75
Moving average 20 days
43.36
Moving average 50 days
47.29
Moving average 100 days
48.83
Price spread / (MMA5)
-0.90%
Price spread / (MMA20)
+5.42%
Price spread / (MMA50)
+14.99%
Price spread / (MMA100)
+18.75%
STIM
RSI 9 days
13.06
RSI 14 days
18.63
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +2.17% | -1.00% | -19.85% | -35.45% | 81.59B | ||
| +0.65% | +1.47% | +40.73% | +92.01% | 734B | ||
| +1.13% | -1.08% | +32.83% | +66.18% | 591B | ||
| +1.09% | -1.90% | -6.30% | -4.86% | 350B | ||
| +0.81% | -4.23% | +15.15% | +14.99% | 315B | ||
| +3.15% | +1.88% | +4.05% | +18.18% | 276B | ||
| +1.35% | -1.73% | +15.00% | +6.02% | 238B | ||
| +2.13% | +0.43% | +9.78% | +7.07% | 206B | ||
| +1.18% | -0.47% | -5.52% | -19.76% | 204B | ||
| +1.59% | -0.23% | +6.17% | +39.94% | 161B | ||
| +1.63% | -0.10% | -0.45% | -22.56% | 160B | ||
| +1.34% | -0.44% | 0.00% | -4.82% | 120B | ||
| +2.11% | -0.65% | +21.81% | +28.85% | 89.9B | ||
| +0.28% | -2.89% | -20.68% | -15.81% | 79.83B | ||
| +3.32% | +3.74% | +44.06% | +22.06% | 66.06B | ||
| -.--% | +1.73% | - | - | 63.66B | ||
| Average | +1.52% | -1.81% | +9.12% | +12.80% | ||
| Weighted average by Cap. | +1.31% | -1.72% | +16.33% | +31.51% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
16bb579c610aaea8923.MnHWcKgMt9gXdhSZ4x1iPvZ12ljB4a5QL8FJTHj9p68.exmJIsFfzrBlAFjKiWRQVochlC-3lNkdF7Y_CUG6499xOKMb_3TigWMSYw
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 21:00:03 | 41.12 | 200 | 22,918,518 |
| 21:00:02 | 41.09 | 9,664,300 | 22,918,318 |
| 21:00:00 | 41.13 | 200 | 13,254,018 |
| 21:00:00 | 41.13 | 500 | 13,253,818 |
| 21:00:00 | 41.13 | 212 | 13,253,318 |
| 21:00:00 | 41.13 | 500 | 13,253,106 |
| 21:00:00 | 41.13 | 300 | 13,252,606 |
| 21:00:00 | 41.13 | 300 | 13,252,306 |
| 20:59:59 | 41.13 | 23,300 | 13,252,006 |
| 20:59:59 | 41.13 | 1,000 | 13,228,706 |
Monthly variations
Annual change
| 2024 | -19.92% | ||
| 2023 | -28.69% | ||
| 2022 | +15.40% | ||
| 2021 | +0.52% | ||
| 2020 | -3.37% | ||
| 2019 | +23.49% | ||
| 2018 | -15.18% | ||
| 2017 | +4.86% | ||
| 2016 | -15.05% | ||
| 2015 | +16.53% | ||
| 2014 | +11.06% | ||
| 2013 | +63.09% | ||
| 2012 | -7.52% | ||
| 2011 | +33.08% | ||
| 2010 | +4.87% | ||
| 2009 | +8.60% | ||
| 2008 | -12.33% | ||
| 2007 | +0.76% | ||
| 2006 | +14.53% | ||
| 2005 | -10.30% | ||
| 2004 | -10.42% | ||
| 2003 | +23.54% | ||
| 2002 | -54.61% | ||
| 2001 | -31.02% | ||
| 2000 | +15.19% | ||
| 1999 | -4.06% | ||
| 1998 | +41.41% | ||
| 1997 | +73.62% | ||
| 1996 | +26.93% | ||
| 1995 | +48.38% | ||
| 1994 | -0.64% | ||
| 1993 | -13.70% | ||
| 1992 | -23.51% | ||
| 1991 | +31.72% | ||
| 1990 | +19.64% | ||
| 1989 | +23.76% | ||
| 1988 | +8.71% | ||
| 1987 | +0.76% | ||
| 1986 | +24.72% | ||
| 1985 | +26.49% | ||
| 1984 | +23.96% | ||
| 1983 | +25.65% | ||
| 1982 | +26.59% | ||
| 1981 | +5.46% | ||
| 1980 | +36.15% | ||
| 1979 | +3.50% | ||
| 1978 | +6.32% | ||
| 1977 | -1.65% | ||
| 1976 | -0.91% | ||
| 1975 | +38.00% | ||
| 1974 | +8.11% | ||
| 1973 | -32.97% | ||
| 1972 | +18.20% | ||
| 1971 | -8.79% | ||
| 1970 | -14.67% | ||
| 1969 | +10.09% | ||
| 1968 | -0.37% |
- Stock Market
- Equities
- BMY Stock
- Quotes Bristol-Myers Squibb Company
